NCT07265583

Brief Summary

The main hypothesis is that even preterm infants considered "stable" receiving non-invasive ventilation may be at risk of developing BPD due to an inhomogeneous distribution of ventilation. Identifying this characteristic from the first days of life by using EIT could, in the future, optimize non-invasive ventilation strategies as early as possible, such as lung recruitment manoeuvres, which are currently mainly used during invasive mechanical ventilation. In addition, comparing the LUS scores and homogeneity parameters derived from the EIT may help to further confirm the role of semi-quantitative lung ultrasound as a rapid, non-invasive, and readily available tool in NICUs for monitoring the lung function of preterm infants in the short and long term. The primary objective is to measure homogeneity by Electrical Impedance Tomography (EIT) technology, used in the first weeks of life, for the development of BPD of grade 3, at 36 weeks postmenstrual age or death, in stable preterm infants requiring non-invasive ventilation. The secondary objective are to score if homogeneity at EIT are present and whether if they are associated with BPD. to ompare the distribution of regional lung ventilation obtained by EIT with the validated LUS scores.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for all trials

Timeline
14mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Oct 2025Jul 2027

First Submitted

Initial submission to the registry

September 9, 2025

Completed
22 days until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 5, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

December 5, 2025

Status Verified

November 1, 2025

Enrollment Period

9 months

First QC Date

September 9, 2025

Last Update Submit

November 24, 2025

Conditions

Keywords

Respiratory distress syndrome RDSpreterm neonate

Outcome Measures

Primary Outcomes (1)

  • The prognostic value of homogeneity of ventilation assessed with EIT

    The primary objective is to measure the benefit of an earlier detection of the risk to develop BPD at 36 weeks postmenstrual age in stable preterm infants requiring non-invasive, in the first weeks of life, scoring the homogeneity of ventilation using EIT technology ventilatio measured by EIT technology, used in the first weeks of life, for the development of BPD at 36 weeks postmenstrual age

    24 months

Secondary Outcomes (3)

  • changes in homogeneity at EIT

    24 months

  • homogeneity at EIT are associated with BPD or death

    24 months

  • EIT and LUS score

    24 months

Eligibility Criteria

Age26 Weeks - 32 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

For this study we will enrol 104 preterm infants born between 26 and 32 weeks of gestational age and/or with a birth weight \< 1500g (very low birth weight infants - VLBW) with respiratory distress syndrome (RDS). The patients are considered eligible to be enrolled in the study if they are assisted in non-invasive ventilation (nasal continuous positive airway pressure -nCPAP- or high flow nasal -HFNC-) at 72h of life.

You may not qualify if:

  • complex congenital malformations
  • metabolic, chromosomal, or other genetic abnormalities
  • pulmonary hypoplasia, congenital anomalies of surfactant proteins or other pulmonary abnormalities
  • any skin anomalies
  • need for mechanical ventilation \> 72h after birth
  • lack of parent consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione IRCCS Policlinico San Matteo

Pavia, 27100, Italy

RECRUITING

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Stefano Ghirardello, MD

    NICU, Fondazione IRCCS Policlinico San Matteo

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Stefano Ghirardello, MD

CONTACT

Francesca Garofoli, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Chief of Neonatal Unit and Neonatal Intensive care Unit

Study Record Dates

First Submitted

September 9, 2025

First Posted

December 5, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2027

Last Updated

December 5, 2025

Record last verified: 2025-11

Locations